The IL3RA antibody TPP-9476 to which the KSP inhibitor payload is linked via a legumain-cleavable peptide linker showed high binding affinity and specificity to IL3RA and bound specifically to IL3RA-expressing human AML and HL cell lines. This evidence concerns the gene IL3RA and acute myeloid leukemia.